Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [(18)F]FDG PET and CT perfusion: a prospective exploratory clinical study

BACKGROUND: Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of response after SABR is difficult. This prospective study aimed to develop a predictive model for true pathologic complete response (pCR...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Yang, Dae-Myoung, Palma, David A., Kwan, Keith, Louie, Alexander V., Malthaner, Richard, Fortin, Dalilah, Rodrigues, George B., Yaremko, Brian P., Laba, Joanna, Gaede, Stewart, Warner, Andrew, Inculet, Richard, Lee, Ting-Yim
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7805034/
https://ncbi.nlm.nih.gov/pubmed/33441162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-021-01747-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi